Microlife 3BTO-A

| Health topic | Maternal mortality |
|---|---|
| Health classification | Diagnosis |
| Type | |
|---|---|
| Authors | |
| Status | Commercialized |
| Years | |
| Made | No |
| Replicated | No |
Problem being addressed
[edit | edit source]Many women in underdeveloped countries suffer from preeclampsia. Preeclampsia is a condition that typically starts after the 20th week of pregnancy and is related to increased blood pressure and protein in the mother's urine (as a result of kidney problems). Preeclampsia affects the placenta, and it can affect the mother's kidney, liver, and brain. When preeclampsia causes seizures, the condition is known as eclampsia--the second leading cause of maternal death in the U.S. Preeclampsia is also a leading cause of fetal complications, which include low birth weight, premature birth, and stillbirth.
Detailed description of the solution
[edit | edit source]It is a blood pressure monitor. This device performs pulse arrhythmia detection. It is clinically tested, very easy to use.
Designed by
[edit | edit source]- Designed by: Microlife Corporation Scientists
- Manufacturer (if different):
- Manufacturer location:
When and where it was tested/implemented
[edit | edit source]Funding Source
[edit | edit source]References
[edit | edit source]Peer-reviewed publication
[edit | edit source]Other internally generated reports
[edit | edit source]Externally generated reports
[edit | edit source]de Greeff A, Nathan H, Stafford N, Liu B, Shennan AH. Development of an accurate oscillometric blood pressure device for low resource settings. Blood Press Monit 2008;13:342-8.
IP and copyright
[edit | edit source]Approval by regulatory bodies or standards boards
[edit | edit source]| Authors | |
|---|---|
| License | CC-BY-SA-3.0 |
| Cite as | Atessa (2012–2022). "Microlife 3BTO-A". Appropedia. Retrieved June 17, 2026. |